Should octreotide be used cautiously in liver cirrhosis with concomitant congestive heart failure correlated to coronary artery disease? | Dig Dis Sci;48(10): 1919, 2003 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Should octreotide be used cautiously in liver cirrhosis with concomitant congestive heart failure correlated to coronary artery disease?

Sorrentino, P; Tarantino, G; Conca, P; Perrella, A.

Dig Dis Sci ; 48(10): 1919, 2003 Oct.

Article in En | MEDLINE | ID: mdl-14627333

Subject(s)

Coronary Disease/complications; Gastrointestinal Agents/adverse effects; Heart Failure/complications; Liver Cirrhosis/complications; Liver Cirrhosis/drug therapy; Octreotide/adverse effects; Vasoconstrictor Agents/adverse effects; Aged; Fatal Outcome; Female; Humans

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Vasoconstrictor Agents / Gastrointestinal Agents / Octreotide / Coronary Disease / Heart Failure / Liver Cirrhosis Limits: Aged / Female / Humans Language: En Journal: Dig Dis Sci Year: 2003 Document type: Article

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Vasoconstrictor Agents / Gastrointestinal Agents / Octreotide / Coronary Disease / Heart Failure / Liver Cirrhosis Limits: Aged / Female / Humans Language: En Journal: Dig Dis Sci Year: 2003 Document type: Article